Amyloidosis of pancreatic islets in primary amyloidosis (AL type)

Pathology International

Volumn 55, Issue 4, 2005, Pages 223-227

  Tomita, Tatsuo ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Amylin; Amyloid a; Amyloid p; Amyloidosis; Congo red; Light chain kappa and lambda; Pancreatic islets

Indexed keywords

AMYLIN; AMYLOID; AMYLOID A PROTEIN; AMYLOID P COMPONENT;

ACINAR CELL; ADULT; AGED; AMYLOIDOSIS; ARTICLE; CELL DEATH; CIRCULATION; CLINICAL ARTICLE; CYTOTOXICITY; FEMALE; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNOCYTOCHEMISTRY; LIGHT CHAIN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AMYLOIDOSIS; AUTOPSY; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PANCREATIC DISEASES; SERUM AMYLOID A PROTEIN; SERUM AMYLOID P-COMPONENT;

EID: 18744411287     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2005.01815.x     Document Type: Article

References (16)

1. Kisilevsky R. Amyloidosis. In: Rubin E, Fisher JL, eds. Pathology, 2nd edn. Philadelphia: JB Lippincott, 1994; 1162-74.
2. Picken MM. The changing concepts of amyloidosis. Arch Pathol Lab Med 2001; 125: 38-43.
3. Gaffney E. Congo red method for amyloid. In: Prophet EB, Mills E, Arrington JB, Sobin LH, eds. Laboratory Methods in Histopathology. Washington, DC: Armed Forces Institutes of Pathology, 1994; 168.
4. Rochen C, Rossner A. An evaluation of antigen retrieval procedures for immunoelectron microscopic classification of amyloid disease. J Histochem Cytochem 1999; 47: 1385-94.
5. Cattoretti G, Becker MGM, Key G, Duckrow M, Shutter C, Galle J. Monoclonal antibodies against recombinant parts of Ki-67 antigen detect proliferating cells in microwave-processed, formalin-fixed, paraffin sections. J Pathol 1992; 13: 389-95.
6. Hoppener JWM, Ahren B, Lips CJM. Islet amyloid in type 2 diabetes mellitus. N Engl J Med 2000; 343; 411-19.
7. Kloppel G. Islet histopathology in diabetes mellitus. In: Kloppel G, Heiz PU, eds. Pancreatic Pathology. Edinburgh: Churchill & Livingston, 1984; 154-92.
8. Kahn SE, Andrikopulos S, Verchere CB. Islet amyloid: a long-recognized but under appreciated pathological feature of type 2 diabetes. Diabetes 1999; 48: 241-53.
9. Wertermark P, Wernstedt C, Wilander E, Sletten K. A novel peptide in the calcitonin gene-related peptide family as an amyloid fibril in the endocrine pancreas. Biochem Biophy Res Commun 1986; 140: 827-31.
10. Tomita T. Amylin in human pancreatic islets. Pathology 2003; 35: 34-6.
11. O'Brien TD, Butler AE, Roche PC, Johnson KH, Butler PC. Islet amyloid polypeptide in human insulinomas. Diabetes 1994; 43: 329-36.
12. Hoppener JWM, Oosterwijk C, Nieuwenhuis MG. Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia 1999; 42: 427-34.
13. Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate sized toxic amyloid particles. Diabetes 1999; 48: 491-8.
14. Bergstrom J, Murphy CL, Weiss DT et al. Two different types of amyloid deposits: apolipoprotein A-IV and transthyretinin in a patient with systemic amyloidosis. Lab Invest 2004; 84: 981-8.
15. Kisilevsky R, Fraser PE. A-beta amyloidogenesis: unique or variation on a systemic themes. Crit Rev Biochem Mol Biol 1997; 32: 361-404.
16. Merlini G, Belloti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003; 349: 583-96.